Australia Audiology Devices Market Analysis Industry Trends and Forecast to 2034: Segmented by (By Product Type, By Technology, By Patient Demographics, By Distribution Channel, By Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
Australia · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$101.4 MnPlaceholder estimate
Estimate 2025$109.4 Mn1.2% of the global market
Projected 2034$217.0 Mn 98.2%Adds $107.5 Mn over 9 forecast years
CAGR 2025–20347.9%Faster than 20% of 173 Medical Devices markets here
15 in AustraliaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Australia. Retrieved 9 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The Australia Audiology Devices Market Executive Summary
Audiology devices refer to any tools that can be used to help people with hearing problems or hearing impairment. These devices include hearing aid, which helps to capture sound to be heard by the ears and the assistive listening devices, which amplify specific sounds in given settings such as during conversations and when watching television. While various hearing aid models have digital technology nowadays, it is possible to find additional features such as active sound therapy, directional microphones, and wireless connectivity. Such devices include hearing aid, cochlear implants, audiometer and bone anchored hearing systems which facilitate enhanced hearing capacity and auditory well-being.
The increase in the global percentage of people aged 60 years and above will be about 1. 4 Bn by 2030, is a key driver of the demand for internet services across the globe. The growth in the global aging population combined with higher incidence of hearing impairments, enhanced awareness, advances in audiology technology and the emergence of new audiology devices are key factors that are steadily fueling the audiology devices market. The European and American markets are most developed in this aspect while the Asia-Pacific region is showing the most growth due to increasing disposable income and increasing healthcare costs. The future of the audiology device market is optimistic due to large population of patients and technological developments while the procedure may have its drawbacks such as high costs and potential backlash from society.
Australia Audiology Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
Australia Audiology Devices Market Dynamics
Market Growth Drivers
Technological progression like integration of Artificial Intelligence and smart hearing devices are improving the usage levels. New markets in Asia, Africa, and the Middle East are significant for growth due to advancing healthcare infrastructure; governmental actions, including the U. S. FDA’s regulations, facilitate enhanced accessibility.
Opportunity
The audiology devices market has immense potential for continued growth due to innovations such as AI, tele-audiology, IoT, and others that make hearing aids more comfortable and convenient for users. New markets are developing in Asia and Africa, and awareness campaigns are being held by governments. The latter is also a resultant of aging population and increased dependency on sustainable and eco-friendly devices that fall under this category thus offering a good potential for growth that can be tapped through investment and enhanced innovation.
Market Restraints
Expenses due to the use of advanced technology and costs in research and development also lead to some devices being expensive and thus unavailable for individuals in the low and middle-income countries. There is also a lack of awareness, especially in developing countries, leading to delayed treatment, and despite the availability of hearing aids, there is still a stigma associated with their use. The policies covering reimbursement are also restricted, and the equipment also requires frequent servicing, which are some of the factors that have a negative impact on the growth of the market.
Competitive Landscape for Audiology Devices Market in Australia
August 2024, Switzerland's Sonova, introduced a hearing aid that utilises real-time artificial intelligence to improve speech clarity from background noise, the first such product in the global market, sending its shares 5% higher.
February 2024, Starkey Launches Genesis AI Hearing Aids in India.
Mergers and Acquisitions
April 2024, Amplifon, a global leader in hearing care services, announced the acquisition of Hearing Instruments, Inc. and Precision Hearing Aid, LLC, two companies owned by a major Miracle-Ear franchisee. This acquisition includes around 35 points of sale in the U.S., the world’s largest hearing care market.
May 2024, Cochlear concludes Oticon Medical cochlear implant acquisition. Cochlear is set to integrate the acquired business over the coming months.
Healthcare Policies and Regulatory Landscape for Audiology Devices Market in Australia
Audiology Devices in Australia: rules, payment and research
Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied.[1] Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines.[2] ClinicalTrials.gov lists 15 studies on Audiology Devices that are recruiting, active or about to start in Australia.[3]
[3]ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Australia. Retrieved 9 Nov 2026.
Policy changes and Reimbursement scenario
Currently under Medicare, reimbursement for hearing aids and audiological assessment is only partial and under Medicaid its availability depends on the state. The move from packaged rates to episodic fee structure, like charging the patient separately for aftercare services, is getting prevalent but it lowers the cap on payments for audiologists. Globally, France has implemented a policy limiting the expenditure on hearing aids to €950 per ear in an effort to increase access. Limited reimbursement policies and awareness of such policies exist in the developed countries hence limiting the use of audiological devices, however with improvement in the health care system the reimbursement policies will improve and hence lead to better access to the audiological devices.
8.2 Government Initiatives / Intervention programs
The audiology devices market is segmented into various categories based on product type, technology, patient demographics, distribution channels, and regional markets. Here’s a detailed overview of the market segmentation:
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Also active in this area, from free public records
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: FDA 510(k) and PMA databases, 510(k) clearances and PMA approvals since 2015 for devices whose name has this market's words. Retrieved 13 Nov 2026.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Audiology Devices right now, from free public sources.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
World Bank.
Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
Audiology Devices in context
Australia compared
Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 15 countries we cover in APAC.[1]
Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 15 countries we cover in APAC.[2]
People aged 65 and over: 18.1% of people (2025). World: 10.4% of people (2025). 3rd highest of the 16 countries we cover in APAC.[3]
[1]World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
How big is the Audiology Devices market in Australia?
Placeholder estimate: about $109.4 Mn in 2025, rising to about $217.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Audiology Devices market in Australia growing?
Placeholder estimate: about 7.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Audiology Devices market report cover?
The report splits the market by product type (Hearing Aids, Cochlear Implants, Bone-anchored Hearing Aids (BAHA), Diagnostic Devices), technology (Digital, Analog), patient demographics (Adults, Pediatrics) and distribution channel (Retail Sales, E-commerce, Government Purchases).
Who are the key players in the Audiology Devices market?
Key players include Amplifon, Audina Hearing Instruments, Inc., Sonova Holding AG, Demant A/S, Audifon GmbH & Co. KG and Starkey Hearing Technologies, among 9 companies the report profiles.
What is driving the Audiology Devices market?
Technological progression like integration of Artificial Intelligence and smart hearing devices are improving the usage levels. New markets in Asia, Africa, and the Middle East are significant for growth due to advancing healthcare infrastructure; governmental actions, including the U.
Who regulates Audiology Devices in Australia?
Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied. Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
How is healthcare paid for in Australia?
Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines. Source: Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
How many clinical trials on Audiology Devices are running in Australia?
15 studies are recruiting, active or about to start in Australia, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Australia. Retrieved 9 Nov 2026.
How much research is published on Audiology Devices?
PubMed lists 10,879 papers on Audiology Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 9 Nov 2026.